AIM
LOXO

Advantage Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Advantage Investment Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-300
Closed -$8K – 1040
2016
Q3 		$8K Hold
300
– – ﹤0.01% 672
2016
Q2 		$7K Hold
300
– – ﹤0.01% 659
2016
Q1 		$8K Hold
300
– – ﹤0.01% 610
2015
Q4 		$9K Hold
300
– – ﹤0.01% 596
2015
Q3 		$5K Hold
300
– – ﹤0.01% 668
2015
Q2 		$5K Hold
300
– – ﹤0.01% 708
2015
Q1 		$4K Hold
300
– – ﹤0.01% 729
2014
Q4 		$4K Buy
+300
New +$3.5K ﹤0.01% 650

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advantage Investment Management's LOXO Position: Q4 2016 in Review

Advantage Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2016, closing a stake of 300 shares — an estimated $8K sold.

Advantage Investment Management first reported a position in LOXO in Q4 2014 and held it in 8 quarters. The position peaked at $9K in Q4 2015. 86 funds tracked by Wall St. Rank hold LOXO as of Q4 2016.

  • Advantage Investment Management reported no remaining Loxo Oncology, Inc position as of Q4 2016 after selling out during the quarter.
  • Advantage Investment Management sold 300 Loxo Oncology, Inc shares in Q4 2016, an estimated $8K.
  • Advantage Investment Management first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 8 quarters.
  • Advantage Investment Management's Loxo Oncology, Inc position peaked at $9K in Q4 2015.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2016.

Based on Advantage Investment Management's 13F filing for Q4 2016, filed 17 Feb 2017.